Edwards Lifesciences CorporationEWNYSE
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
9.36%
↓ 22% below average
Average (9y)
12.02%
Historical baseline
Range
High:24.97%
Low:1.06%
CAGR
-1.3%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 9.36% |
| 2023 | 1.87% |
| 2022 | 4.66% |
| 2021 | 18.72% |
| 2020 | 1.06% |
| 2019 | 20.97% |
| 2018 | 12.60% |
| 2017 | 24.97% |
| 2016 | 15.43% |
| 2015 | 10.56% |